| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2016-08-07 | dMAb® DNA targeting HIV | HIV infection | Inovio Pharmaceuticals (USA - PA) | Infectious diseases | |
| 2016-08-05 | cariprazine | major depressive disorder | 3 | Gedeon Richter (Hungary) Allergan (Ireland) | CNS diseases - Mental diseases |
| 2016-08-04 | ReN001 (CTX cell therapy) | stroke | 1 | Reneuron (UK) | Cerebrovascular diseases |
| 2016-08-04 | Grafix® | complex diabetic foot wounds | 4 | Osiris Therapeutics (USA - MD) | Regenerative Medicine |
| 2016-08-04 | necuparanib (M402) in combination with Abraxane® (paclitaxel) and gemcitabine | metastatic pancreatic cancer | 1-2 | Momenta Pharmaceuticals (USA - MA) | Cancer - Oncology |
| 2016-08-03 | AB-SA01 (phage cocktail targeting Staphylococcus aureus) | Staphylococcus aureus infections | 1 | AmpliPhi BioSciences (USA - VA) | Infectious diseases |
| 2016-08-03 | heat stable subunit Ebola vaccine | Ebola fever | Soligenix (USA - NJ) Hawaii Biotech (USA - HI) University of Hawaii (USA - HI) | Infectious diseases | |
| 2016-08-02 | PM1183 (lurbinectedin) in combination with doxorubicin | small cell lung cancer (SCLC) after the failure of one prior platinum containing line | 3 | PharmaMar (Spain) | Cancer - Oncology |
| 2016-08-01 | RHB-104 | relapsing remitting multiple sclerosis (RRMS) | 2 | Redhill Biopharma (Israel) | Autoimmune diseases - Neurodegenerative diseases |
| 2016-07-29 | pembrolizumab (MK-3475) | urothelial carcinoma | 3 | Merck&Co (USA - NJ) | Cancer - Oncology |
| 2016-07-29 | pembrolizumab (MK-3475) and axitinib | renal cell carcinoma | 3 | Merck&Co (USA - NJ) | Cancer - Oncology |
| 2016-07-29 | tepotinib | lung adenocarcinoma stage IIIB/IV | 2 | Merck KGaA (Germany) | Cancer - Oncology |
| 2016-07-28 | emicizumab (ACE910 - anti-factor IXa x anti-factor X humanized bispecific antibody) | hemophilia A | 1-2 | Chugai Pharmaceutical (Japan) | Rare diseases - Genetic diseases - Hematological diseases |
| 2016-07-28 | fimaporfin - disulfonated tetraphenyl chlorin (TPCS2a) (Amphinex™) | advanced solid tumours | 1 | PCI Biotech (Norway) | Cancer - Oncology |
| 2016-07-28 | BI 695501 (biosimilar version of Humira® (adalimumab)) | psoriasis | 3 | Boehringer Ingelheim (Germany) | Autoimmune diseases - Dermatological diseases |
| 2016-07-26 | ND0701 (apomorphine-base) | Parkinson's disease | Neuroderm (Israel) | Neurodegenerative diseases | |
| 2016-07-26 | synthetic vaccine for the Zika virus GLS-5700 | Zika virus infection | 1 | Inovio Pharmaceuticals (USA - PA) GeneOne Life Science (Republic of Korea) | Infectious diseases |
| 2016-07-26 | galeterone | prostate cancer | 3 | Tokai Pharmaceuticals (USA - MA) | Cancer - Oncology |
| 2016-07-25 | roxadustat | anemia associated with chronic kidney disease (CKD) | 3 | FibroGen (USA - CA) Astellas Pharma (Japan) | Kidney diseases - Renal diseases |
| 2016-07-25 | VLA84 | Clostridium difficile infection | 2 | Valneva (France - Austria) | Infectious diseases |
